Assessment of Somatic Symptom Burden

Sponsor
RenJi Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03321409
Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (Other), Peking University People's Hospital (Other), The First Affiliated Hospital of Zhengzhou University (Other)
2,000
1
57
35.1

Study Details

Study Description

Brief Summary

The Patient Health Questionnaire-15 (PHQ-15) is a frequently used questionnaire to assess somatic symptom burden. The Somatic Symptom Scale China (SSS-CN) was recently developed as a comprehensive self-report instrument in assessing somatic symptom burden, but its assessment value has not yet been widely tested in a nationwide. The study aims to investigate the reliability of the SSS-CN, to validate discriminate validity and factorial validity, and to investigate its utility in patients with suspected coronary artery disease (CAD) based on multi-centers inpatients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: The general population
  • Diagnostic Test: Patients with suspected CAD

Detailed Description

Somatic symptoms are prevalent in kinds of medical conditions and mental disorders. Since they are associated with decreased quality of life, increased psychological distress, and increased use of health care services, the assessment of somatic symptom burden is essential in evidence based patient care and research. The Patient Health Questionnaire-15 (PHQ-15) is a frequently used questionnaire to assess somatic symptom burden, but in which there are not any mental symptoms listed. Recently, we developed the Somatic Symptom Scale China (SSS-CN) which includes common mental symptoms and more comprehensive somatic symptoms to assess somatic symptom burden, but its assessment value has not yet been widely tested.

The aim of our study is to investigate the reliability and validity of the SSS-CN compared with the PHQ-15. We also try to use the SSS-CN to investigate the prevalence of somatic symptoms in patients with suspected coronary artery disease (CAD) based on multi-centers inpatients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
2000 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
The Validation of the Somatic Symptom Scale China (SSS-CN) for Assessing Somatic Symptom Burden and Its Utility in Patients With Suspected Coronary Artery Disease
Actual Study Start Date :
Sep 1, 2017
Anticipated Primary Completion Date :
May 1, 2021
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
The general population

People who take the physical examination in Renji Hospital between 18 to 80 years old without any previously confirmed serious medical conditions or mental disorders.

Diagnostic Test: The general population
After recruiting participants, collecting the baseline data, the SSS-CN and PHQ-15 will be carried out. Then validating the reliability, validity of the SSS-CN will be compared with the PHQ-15.
Other Names:
  • SSS-CN and PHQ-15 questionnaire
  • The patients with suspected CAD

    Patients with suspected CAD between 18 to 80 years old without any previously confirmed serious medical conditions or mental disorders.

    Diagnostic Test: Patients with suspected CAD
    In patients with suspected CAD, after recruiting participants, collecting the baseline data, the SSS-CN and PHQ-15 will be carried out before undergo coronary angiography. Then the prevalence of somatic symptoms will be investigated.
    Other Names:
  • SSS-CN and PHQ-15 questionnaire before coronary angiography
  • Outcome Measures

    Primary Outcome Measures

    1. The score of the SSS-CN in the general population [Within 24 hours after collecting the scale.]

      To investigate the cutoff, reliability and validity of the SSS-CN according to the score. The Somatic Symptom Scale China (SSS-CN) is developed to assess somatic symptom burden, which includes 20 items. Each item represents an organ discomfort and is rated as 1 ("not at all"), 2 ("mild"), 3("moderate"), or 4 ("severe"). In determining the SSS-CN score, the total score is summarized from the 20 items, rendering ranges from 20 to 80 (higher scores represent the more severe somatic symptom burden).

    Secondary Outcome Measures

    1. Number of participants with somatic burden in suspected CAD patients [Within 24 hours after the coronary angiography.]

      To validate the utility of SSS-CN and investigate the prevalence of somatic burden in patients with suspected CAD as assessed by SSS-CN.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. People who take the physical examination in Renji Hospital.

    2. Patients with suspected CAD.

    Exclusion Criteria:
    1. People who have been previously confirmed serious medical conditions.

    2. People who have been previously confirmed serious mental disorders.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Renji Hospital Shanghai China 200127

    Sponsors and Collaborators

    • RenJi Hospital
    • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
    • Peking University People's Hospital
    • The First Affiliated Hospital of Zhengzhou University

    Investigators

    • Study Chair: Meng Jiang, MD, RenJi Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    RenJi Hospital
    ClinicalTrials.gov Identifier:
    NCT03321409
    Other Study ID Numbers:
    • SSS201709
    First Posted:
    Oct 25, 2017
    Last Update Posted:
    Dec 8, 2020
    Last Verified:
    Oct 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by RenJi Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 8, 2020